And keep in mindthis list of covered GLP-1s could change over the course of the Bridge program
While theres debate about how it works, the addition of GIP in this case may be increasing the effectiveness of GLP-1, creating an added weight loss effect
Liraglutide had a similar effect but to a slightly lesser extent, which the authors attribute to differences in doses and treatment approach of the two drugs
Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: results from the EMPA-REG OUTCOME trial
Current AD research focuses on understanding pathology by targeting several mechanisms, such as abnormal tau protein metabolism, -amyloid, inflammatory response, and cholinergic and free radical damage, aiming to develop successful treatments that are capable of stopping or modifying the course of AD (Tamagno et al., 2021)